News | January 06, 2026
Nia Therapeutics unveils first implantable brain interface for memory disorders
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
The study will run across 18 sites and enroll roughly 200 patients over 24 months
Harbour BioMed brings advanced antibody discovery platforms to the table
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
The proceeds from the QIP will be used primarily to accelerate the nationwide expansion of the COCO stores of Davaindia nationwide
The opening of our 1000th pharmacy in Karnataka marks an important step
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
NUFYMCO BLA has been approved by the USFDA
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The initiative is focused on a problem that continues to plague cancer outcomes in India
Subscribe To Our Newsletter & Stay Updated
